EdgarLookup

Hanover Bancorp, Inc. /MD — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Hanover Bancorp, Inc. /MD filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.3%
Return on Assets
Net income ÷ assets
10.9x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.49M Mar 13, 2026
FY2025 Dec 31, 2024 $12.35M Mar 13, 2026
FY2024 Dec 31, 2023 $3.76M Mar 14, 2025
FY2024 Sep 30, 2023 $15.16M Mar 14, 2025
FY2023 Sep 30, 2022 $23.56M Dec 21, 2023
FY2022 Sep 30, 2021 $10.85M Dec 23, 2022
FY2021 Sep 30, 2020 $4.97M Dec 23, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $13.05M Mar 13, 2026
FY2025 Dec 31, 2024 $5.44M Mar 13, 2026
FY2024 Dec 31, 2023 $4.11M Mar 14, 2025
FY2024 Sep 30, 2023 $16.40M Mar 14, 2025
FY2023 Sep 30, 2022 $25.08M Dec 21, 2023
FY2022 Sep 30, 2021 $13.19M Dec 23, 2022
FY2021 Sep 30, 2020 $566.0K Dec 23, 2021

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $869.0K Mar 13, 2026
FY2025 Dec 31, 2024 $1.29M Mar 13, 2026
FY2024 Dec 31, 2023 $356.0K Mar 14, 2025
FY2024 Sep 30, 2023 $3.41M Mar 14, 2025
FY2023 Sep 30, 2022 $1.12M Dec 21, 2023
FY2022 Sep 30, 2021 $2.08M Dec 23, 2022
FY2021 Sep 30, 2020 $1.09M Dec 23, 2021

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.38B Mar 13, 2026
FY2025 Dec 31, 2024 $2.31B Mar 13, 2026
FY2024 Dec 31, 2023 $2.27B Mar 14, 2025
FY2024 Sep 30, 2023 $2.15B Mar 14, 2025
FY2023 Sep 30, 2022 $1.84B Dec 21, 2023
FY2022 Sep 30, 2021 $1.48B Dec 23, 2022
FY2021 Sep 30, 2020 $851.61M Dec 23, 2021

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.18B Mar 13, 2026
FY2025 Dec 31, 2024 $2.12B Mar 13, 2026
FY2024 Dec 31, 2023 $2.09B Mar 14, 2025
FY2024 Sep 30, 2023 $1.96B Mar 14, 2025
FY2023 Sep 30, 2022 $1.67B Dec 21, 2023
FY2022 Sep 30, 2021 $1.36B Dec 23, 2022
FY2021 Sep 30, 2020 $773.56M Dec 23, 2021

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $200.27M Mar 13, 2026
FY2025 Dec 31, 2024 $196.64M Mar 13, 2026
FY2025 Dec 31, 2023 $184.83M Mar 13, 2026
FY2024 Sep 30, 2023 $185.91M Mar 14, 2025
FY2024 Sep 30, 2022 $172.58M Mar 14, 2025
FY2023 Sep 30, 2021 $122.53M Dec 21, 2023
FY2022 Sep 30, 2020 $78.04M Dec 23, 2022
FY2021 Sep 30, 2019 $71.95M Dec 23, 2021

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $19.17M Mar 13, 2026
FY2025 Dec 31, 2024 $19.17M Mar 13, 2026
FY2025 Dec 31, 2023 $19.17M Mar 13, 2026
FY2024 Sep 30, 2023 $19.17M Mar 14, 2025
FY2024 Sep 30, 2022 $19.17M Mar 14, 2025
FY2023 Sep 30, 2021 $19.17M Dec 21, 2023
FY2022 Sep 30, 2020 $1.90M Dec 23, 2022
FY2021 Sep 30, 2019 $1.48M Dec 23, 2021

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $72.40M Mar 13, 2026
FY2025 Dec 31, 2024 $67.92M Mar 13, 2026
FY2024 Dec 31, 2023 $58.55M Mar 14, 2025
FY2024 Sep 30, 2023 $58.69M Mar 14, 2025
FY2023 Sep 30, 2022 $46.48M Dec 21, 2023
FY2022 Sep 30, 2021 $24.97M Dec 23, 2022
FY2021 Sep 30, 2020 $14.12M Dec 23, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $208.90M Mar 13, 2026
FY2025 Dec 31, 2024 $162.86M Mar 13, 2026
FY2024 Dec 31, 2023 $177.21M Mar 14, 2025
FY2024 Sep 30, 2023 $192.62M Mar 14, 2025
FY2023 Sep 30, 2022 $149.95M Dec 21, 2023
FY2022 Sep 30, 2021 $166.54M Dec 23, 2022
FY2021 Sep 30, 2020 $80.21M Dec 23, 2021

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 13, 2026
FY2025 Dec 31, 2024 1 Mar 13, 2026
FY2024 Dec 31, 2023 0 Mar 14, 2025
FY2024 Sep 30, 2023 2 Mar 14, 2025
FY2023 Sep 30, 2022 3 Dec 21, 2023
FY2022 Sep 30, 2021 2 Dec 23, 2022
FY2021 Sep 30, 2020 1 Dec 23, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Mar 13, 2026
FY2025 Dec 31, 2024 1 Mar 13, 2026
FY2024 Dec 31, 2023 0 Mar 14, 2025
FY2024 Sep 30, 2023 2 Mar 14, 2025
FY2023 Sep 30, 2022 3 Dec 21, 2023
FY2022 Sep 30, 2021 2 Dec 23, 2022
FY2021 Sep 30, 2020 1 Dec 23, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7.14M Mar 13, 2026
FY2025 Dec 31, 2024 7.15M Mar 13, 2026
FY2024 Dec 31, 2023 7.20M Mar 14, 2025
FY2024 Sep 30, 2023 7.17M Mar 14, 2025
FY2023 Sep 30, 2022 7.29M Dec 21, 2023
FY2022 Sep 30, 2021 5.56M Dec 23, 2022
FY2021 Sep 30, 2020 4.18M Dec 23, 2021

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2023 Sep 30, 2023 $2.93M Dec 21, 2023
FY2023 Sep 30, 2022 $2.04M Dec 21, 2023
FY2022 Sep 30, 2021 $0 Dec 23, 2022